nocodazole has been researched along with Epithelial Ovarian Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santibáñez, M | 1 |
| Gallardo, D | 1 |
| Morales, F | 1 |
| López, A | 1 |
| Prada, D | 1 |
| Mendoza, J | 1 |
| Castro, C | 1 |
| de León, DC | 1 |
| Oñate, LF | 1 |
| Perez, D | 1 |
| Mohar, A | 1 |
| Herrera, LA | 1 |
1 other study available for nocodazole and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
The MAD1 1673 G → A polymorphism alters the function of the mitotic spindle assembly checkpoint and is associated with a worse response to induction chemotherapy and sensitivity to treatment in patients with advanced epithelial ovarian cancer.
Topics: Biomarkers, Pharmacological; Calcium-Binding Proteins; Carcinoma, Ovarian Epithelial; Cell Cycle Pro | 2013 |